Rua Bioscience Ltd. (NZ:RUA)
:RUA
Want to see NZ:RUA full AI Analyst Report?
Total Valuation
Rua Bioscience Ltd. has a market cap or net worth of $10.48M. The enterprise value is 7.65M.
Market Cap$10.48M
Enterprise Value7.65M
Share Statistics
Rua Bioscience Ltd. has 338,041,720 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding338,041,720
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Rua Bioscience Ltd.’s return on equity (ROE) is -0.71 and return on invested capital (ROIC) is -58.61%.
Return on Equity (ROE)-0.71
Return on Assets (ROA)-0.51
Return on Invested Capital (ROIC)-58.61%
Return on Capital Employed (ROCE)-0.67
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover0.28
Inventory Turnover2.41
Valuation Ratios
The current PE Ratio of Rua Bioscience Ltd. is ―. Rua Bioscience Ltd.’s PEG ratio is 0.02.
PE Ratio―
PS Ratio2.55
PB Ratio0.99
Price to Fair Value0.99
Price to FCF-1.78
Price to Operating Cash Flow-4.03
PEG Ratio0.02
Income Statement
In the last 12 months, Rua Bioscience Ltd. had revenue of 1.90M and earned -3.46M in profits. Earnings per share was -0.02.
Revenue1.90M
Gross Profit923.23K
Operating Income-3.30M
Pretax Income-3.46M
Net Income-3.46M
EBITDA-2.92M
Earnings Per Share (EPS)-0.02
Cash Flow
In the last 12 months, operating cash flow was -2.30M and capital expenditures 1.52M, giving a free cash flow of -779.47K billion.
Operating Cash Flow-2.30M
Free Cash Flow-779.47K
Free Cash Flow per Share>-0.01
Dividends & Yields
Rua Bioscience Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.07
52-Week Price Change25.00%
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)―
Important Dates
Rua Bioscience Ltd. upcoming earnings date is Aug 31, 2026, After Close (Confirmed).
Last Earnings DateFeb 26, 2026
Next Earnings DateAug 31, 2026
Ex-Dividend Date―
Financial Position
Rua Bioscience Ltd. as a current ratio of 1.25, with Debt / Equity ratio of 31.56%
Current Ratio1.25
Quick Ratio1.03
Debt to Market Cap0.14
Net Debt to EBITDA-0.17
Interest Coverage Ratio-20.60
Taxes
In the past 12 months, Rua Bioscience Ltd. has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Rua Bioscience Ltd. EV to EBITDA ratio is -1.82, with an EV/FCF ratio of -1.96.
EV to Sales2.81
EV to EBITDA-1.82
EV to Free Cash Flow-1.96
EV to Operating Cash Flow-1.96
Balance Sheet
Rua Bioscience Ltd. has $2.17M in cash and marketable securities with $1.84M in debt, giving a net cash position of $321.90K billion.
Cash & Marketable Securities$2.17M
Total Debt$1.84M
Net Cash$321.90K
Net Cash Per Share<$0.01
Tangible Book Value Per Share$0.02
Margins
Gross margin is -30.32%, with operating margin of -173.59%, and net profit margin of -181.90%.
Gross Margin-30.32%
Operating Margin-173.59%
Pretax Margin-181.90%
Net Profit Margin-181.90%
EBITDA Margin-153.85%
EBIT Margin-171.68%
Analyst Forecast
The average price target for Rua Bioscience Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast182.06%
EPS Growth Forecast48.24%